HHS said Feb. 4 it is working with Regeneron Pharmaceuticals to develop a treatment for the coronavirus.
The agency said it will work to develop multiple monoclonal antibodies, which help block a virus from infecting human cells.
Regeneron previously worked on a similar treatment for Ebola and MERS.
Read the full news release here.